Latest Breaking News On - Consilium strategic communications - Page 6 : comparemela.com

MoonLake Immunotherapeutics to host a Capital Markets Day on Monday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Day on Monday, September 11 ZUG, Switzerland, September 6, 2023 – MoonLake Immunotherapeutics AG , a clinical-stage biotechnology company.

United statesJosephf merolaPatricia sousaMoonlake immunotherapeuticsNamrata taakAshley tappMary jane elliottMatthias bodenstedtDepartment of medicineDivision of rheumatologyInternational hidradenitis suppurativa severity score systemDepartment of dermatologyProfessor at harvard medical schoolHealth assessment questionnaireAmerican college of rheumatologyConsilium strategic communications

Syncona : Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer -Today at 09:20 am

Appointments of Fredrik and Peter complete build-out of senior team London- 6 September 2023- Purespring Therapeutics, a pioneering gene therapy company focused on transforming.

Jessica hodgsonFredrik erlandssonPeter mulcahyAmber fennellKorsuva kapruviaMoin saleemJulian hanakChris hollowoodConsilium strategic communicationsSyncona ltdHead global clinical developmentUniversity of bristolKarolinska instituteFredrik erlandsonChief medical officerChief people

MaxCyte to Participate in Baird Global Healthcare Conference

ROCKVILLE, Md., Sept. 05, 2023 MaxCyte, Inc., , a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as.

United kingdomDavid deuchlerRupert deardenEmma earl freddy crossleyPanmure gordonMary jane elliottChris welshMaxcyte incGilmartin groupConsilium strategic communicationsBaird global healthcare conferenceFlow electroporationCyte contactsJoint corporateFreddy crossleyJane elliott

SparingVision Reports Positive Initial Safety Data from the first cohort treated in its PRODYGY Phase I/II Gene Therapy Trial

SparingVision Reports Positive Initial Safety Data from the first cohort treated in its PRODYGY Phase I/II Gene Therapy Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesAmber fennellAvril dalyDavide salviNamrata taakNathalie trepoJoseph martelUniversity of pittsburgh medical centerConsilium strategic communicationsNational hospitalEye centerParis vision instituteRd fundRetina internationalSparingvision the company

Xeltis secures additional €12 5 million from European Innovation Council Fund in final close of D2 financing

Xeltis secures additional €12 5 million from European Innovation Council Fund in final close of D2 financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlexander goemansAmber fennell chris welshEliane schutteApril xeltisEuropean innovation council fundEuropean commissionPharma groupEuropean innovation councilLife sciencesDavita venture groupConsilium strategic communicationsEuropean commission horizon europeFund boardsaidHorizon europeKurma partners